The Reliability and Validity of the L-test in Patients With Multiple Sclerosis
1 other identifier
observational
68
1 country
1
Brief Summary
Walking safely inside or outside is an important function in patients with Multiple Sclerosis (PwMS) that affects their daily life activity and participation. Loss of functional mobility is the major component of walking disorders in PwMS. Therefore, it is important to evaluate functional mobility. Many functional mobility tests have been used for PwMS; however, these tests generally focus on walking speed and endurance. On the other hand, the L test, a variation of the timed up and go test (TUG), is a functional mobility measurement tool that extends the total walking distance to 20 meters and also requires the patients to turn both clockwise and counterclockwise. Although L the test is an easy-to-use, short-term test method that evaluates higher-level components of functional mobility such as turns and transfers, to our knowledge, no study has systematically examined the reliability and validity of the L test in PwMS yet. In addition, the cut-off times that best discriminate PwMS from healthy people and fallers with non-fallers with Multiple Sclerosis (MS) have not been reported. Therefore, this study planned to investigate the reliability, validity, and discrimination of the L test in PwMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2022
CompletedFirst Posted
Study publicly available on registry
December 8, 2022
CompletedStudy Start
First participant enrolled
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2023
CompletedFebruary 23, 2023
February 1, 2023
1 month
November 24, 2022
February 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
L test
The L test evaluates functional mobility. Higher durations indicate worse functional mobility performance.
baseline
L test-second assessment
The L test evaluates functional mobility. Higher durations indicate worse functional mobility performance.
the second assessment will be conducted after the seven days
Secondary Outcomes (4)
Timed Up and Go test
Baseline
10 meter walk test
Baseline
6 minute walk test
Baseline
the timed 360° turn test
Baseline
Study Arms (2)
multiple sclerosis
Patients with Multiple Sclerosis
healthy controls
healthy controls
Interventions
The test includes standing up from a chair, walking in a straight line for 3 m, turning to the right, walking in a straight line for 7 m, turning around, walking back 7 m along the same line, turning to the left, walk 3 m in a straight line to the chair, and then sit down.
The test requires the individual to stand up from an armed chair, walk 3m, turn around, walk back to the armed chair, and sit down again.
In the test, the clinician measures the time taken to walk a distance of 10 m from a standing position. Participants are asked to walk along a 14 m long walkway.
This test measures the distance (in m) that an individual is able to walk at a comfortable speed for 6 minutes. Starting from a standing position, participants walk continuously around two pylons placed 30 m apart for 6 minutes. The distance is recorded end of the test.
Each participant turns around in place in a standing position for both sides.
Eligibility Criteria
Patients with Multiple Sclerosis who apply to Gazi University, Department of Physiotherapy and Rehabilitation will be invited to this study.
You may qualify if:
- Age at least 18 years,
- Neurologist-diagnosed Multiple Sclerosis,
- Expanded Disability Status Scale (EDSS) score between 0-5,
- No MS exacerbation within the last 3 months,
- Use of stable medication in the last 3 months.
You may not qualify if:
- Having any vision, hearing, or perception problems that may affect the research results,
- Having an orthopedic problem that will prevent walking and standing
- Having a cardiovascular, pulmonary, or hormonal disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University
Ankara, Turkey (Türkiye)
Related Publications (3)
Kim JS, Chu DY, Jeon HS. Reliability and validity of the L test in participants with chronic stroke. Physiotherapy. 2015 Jun;101(2):161-5. doi: 10.1016/j.physio.2014.09.003. Epub 2014 Oct 28.
PMID: 25555897BACKGROUNDDeathe AB, Miller WC. The L test of functional mobility: measurement properties of a modified version of the timed "up & go" test designed for people with lower-limb amputations. Phys Ther. 2005 Jul;85(7):626-35.
PMID: 15982169BACKGROUNDEldemir K, Eldemir S, Ozkul C, Irkec C, Guclu-Gunduz A. Reliability and validity of the L test in people with multiple sclerosis. Physiotherapy. 2025 Mar;126:101429. doi: 10.1016/j.physio.2024.101429. Epub 2024 Sep 24.
PMID: 39541755DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
November 24, 2022
First Posted
December 8, 2022
Study Start
December 15, 2022
Primary Completion
January 16, 2023
Study Completion
January 16, 2023
Last Updated
February 23, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share